FDA NDC Directory · JSON-LD · Markdown

Scopolamine Transdermal System

NDC 45802-580 · HUMAN PRESCRIPTION DRUG · PATCH, EXTENDED RELEASE

Generic namescopolamine transdermal system
Labeler / ManufacturerPadagis Israel Pharmaceuticals Ltd
Marketing categoryAbbreviated NDA (generic) · App ANDA078830
Dosage form / routePATCH, EXTENDED RELEASE · TRANSDERMAL
Active ingredientsSCOPOLAMINE (1 mg/1)
Marketing started20170613
Marketing ended20280630
Package count3

External sources

Source: openFDA. Public-domain (CC0).